Фармацевтични грижи при хора с разстройства от тревожно-депресивния спектър – пилотно проучване
Pharmaceutical care for anxiety and depressive disorders - a pilot study

Summary/Abstract: Background: Pharmaceutical care is an essential part of the total care for people with mental health problems. Globally, anxiety and depression are major causes of mental health-related burden of diseases. These disorders are often “hidden” because of comorbidity. Late consultation with a psychiatrist, delayed treatment, improper therapeutic plan, and poor compliance to the prescribed treatment can lead to disease progression and disability. Treatment with antidepressants is a standard approach to depressive and anxiety patients, but effective treatment needs to be strict. Poor compliance to treatment is related to side effects, poor patient awareness, polypragmasia, lack of communication with healthcare professionals. The aim of the article is to present a pilot study, which investigates the role of the pharmacist in: 1) the screening of people related to anxiety and depressive symptoms and 2) the improvement of the compliance of the patients with depression and anxiety to a prescribed treatment. Material and methods: Standardized questionnaires: The Patient Health Questionnaire PHQ-2 и PHQ-9, Moricki test, self-completed questionnaire. The preliminary results proved that the pharmacists are a valuable resource and, as the most accessible healthcare professionals, can differentiate people at risk for depression and anxiety who seek counseling for particular symptoms at the pharmacy and can be referred to a physician. Further, poor compliance to therapy can be overcome by effective physician-patient-pharmacist communication.

• Details
• Contents